Psyence Biomedical PBM
NASDAQ PBM
$4.33 +0.40 (+10.18%)
At close: Aug 21, 2026 · 4:00 PM EDT

Psyence Biomedical Ltd. (PBM) Interest Expenses (2023 - 2025)

Psyence Biomedical (PBM) posted quarterly Interest Expenses of -$2753.0 for Q3 2025, down 174.1% year-over-year from $3715.0 in Q3 2024, and down 174.1% quarter-over-quarter from $3715.0 in Q3 2024.

Psyence Biomedical Ltd. (PBM) Interest Expenses (2023 - 2025) Analysis & Trends

Psyence Biomedical's Interest Expenses history runs 3 years deep, the most recent figure standing at -$2753.0 for Q3 2025.

  • In Q3 2025, Interest Expenses fell 174.1% year-over-year to -$2753.0; the TTM figure through Mar 2026 stood at $962.0 (down 74.1% YoY), while the FY2026 annual figure was $9522.0, up 2.72% from the prior year.
  • Interest Expenses for Q3 2025 stood at -$2753.0, down from $3715.0 in the prior quarter.
  • The five-year high for Interest Expenses was $27936.0 in Q1 2023, with the low at -$2753.0 in Q3 2025.
  • The 3-year median for Interest Expenses is $3715.0 (2024), against an average of $9632.7.
  • Peak annual rise in Interest Expenses reached 174.1% in 2025, while the deepest fall reached 174.1% in 2025.
  • Psyence Biomedical's Interest Expenses stood at $27936.0 in 2023, then plunged by 86.7% to $3715.0 in 2024, then sank by 174.1% to -$2753.0 in 2025.
  • Business Quant data shows PBM's Interest Expenses at -$2753.0 in Q3 2025, $3715.0 in Q3 2024, and $27936.0 in Q1 2023.

Peer Comparison

Historic Data

Download Data
DateValue
Sep 30, 2025 -2,753.00
Sep 30, 2025 -2,753.00
Sep 30, 2024 3,715.00
Sep 30, 2024 3,715.00
Mar 31, 2023 27,936.00
Mar 31, 2023 27,936.00